How do you approach management of bone marrow involvement in sarcoidosis?  

This is an excellent question that certainly comes up frequently enough among sarcoidosis patients, and unfortunately with little guidance. Osseous involvement of sarcoidosis can include the bone marrow, leading to cytopenias. The levels of cytopenias can vary, and risk versus benefit should be take...

Monoclonal TNF inhibition would be an option as it is less likely to cause cytopenias and has shown some effectiveness in extrapulmonary Sarcoid. I have 2 patients who have anecdotally who have done well in the past.

Hematological abnormalities described in patients with sarcoidosis include leukopenia, anemia and thrombocytopenia. Pancytopenia is rarer but responds favorably corticosteroid therapy. A steroid sparing agent can be started once the pancytopenia has improved. TNF inhibitors are a great option when p...

Cytopenias due to sarcoidosis don’t always require treatment. Leukopenia and anemia are more common than thrombocytopenia. Isolated bone marrow involvement is also not very common and sometimes treatment indication/choice is guided by other potential organs involved. Agree with previous answer...

I would consider more cytopenic friendly meds: TNF, JAK over MMF or imuran. However, like most things in rheum it is the sarcoid causing the cytopenia then any TX that works is the goal. Would probably check counts q2 weeks as uptitration of more cytopenic agents and as counts improve q4 weeks x3 mo...